| Martin J Finn, MD | |
|
675 W North Ave, Suite 510, Melrose Park, IL 60160-1634 | |
| (708) 450-4551 | |
| (708) 681-9711 |
| Full Name | Martin J Finn |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 42 Years |
| Location | 675 W North Ave, Melrose Park, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922005792 | NPI | - | NPPES |
| 036068656 | Medicaid | IL | |
| 1616108 | Other | IL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036068656 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Oak Park Dialysis Unit | Oak park, IL | Dialysis facility |
| Fmc - North Avenue Dialysis Center | Melrose park, IL | Dialysis facility |
| Fmc - West Suburban Dialysis Center | Oak park, IL | Dialysis facility |
| West Suburban Medical Center | Oak park, IL | Hospital |
| Rush Oak Park Hospital | Oak park, IL | Hospital |
| Gottlieb Memorial Hospital | Melrose park, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Of Northern Illinois Ltd | 2163328675 | 97 |
News Archive
Actelion Ltd announced today that findings from the REVEAL Registry have confirmed the clinical utility of the REVEAL risk score calculator, a new tool designed to predict 1-year survival in patients with pulmonary arterial hypertension according to data presented at the American Thoracic Society's Annual International Conference.
Researchers at Karolinska Institutet in Sweden have imaged tau protein in the brains of living patients with Alzheimer's disease.
The desire for a quick-fix for obesity fuels a lucrative market in so-called natural remedies. But a study of medical records in Hong Kong revealed 66 cases where people were suspected to have been poisoned by a "natural" slimming therapy. In eight cases the people became severely ill, and in one case the person died. The study is published today in the British Journal of Clinical Pharmacology.
Hythiam, Inc. (NASDAQ:HYTM) announced today that on September 15, 2009, the Company received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock had closed below the minimum $1.00 per share threshold as set forth in NASDAQ Listing Rule 5450(a)(1) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.
› Verified 3 days ago
| Entity Name | Nephrology Associates Of Northern Illinois Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124069182 PECOS PAC ID: 2163328675 Enrollment ID: O20031208000313 |
News Archive
Actelion Ltd announced today that findings from the REVEAL Registry have confirmed the clinical utility of the REVEAL risk score calculator, a new tool designed to predict 1-year survival in patients with pulmonary arterial hypertension according to data presented at the American Thoracic Society's Annual International Conference.
Researchers at Karolinska Institutet in Sweden have imaged tau protein in the brains of living patients with Alzheimer's disease.
The desire for a quick-fix for obesity fuels a lucrative market in so-called natural remedies. But a study of medical records in Hong Kong revealed 66 cases where people were suspected to have been poisoned by a "natural" slimming therapy. In eight cases the people became severely ill, and in one case the person died. The study is published today in the British Journal of Clinical Pharmacology.
Hythiam, Inc. (NASDAQ:HYTM) announced today that on September 15, 2009, the Company received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock had closed below the minimum $1.00 per share threshold as set forth in NASDAQ Listing Rule 5450(a)(1) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martin J Finn, MD 120 W 22nd St Ste 200, Oak Brook, IL 60523-1563 Ph: (630) 573-5000 | Martin J Finn, MD 675 W North Ave, Suite 510, Melrose Park, IL 60160-1634 Ph: (708) 450-4551 |
News Archive
Actelion Ltd announced today that findings from the REVEAL Registry have confirmed the clinical utility of the REVEAL risk score calculator, a new tool designed to predict 1-year survival in patients with pulmonary arterial hypertension according to data presented at the American Thoracic Society's Annual International Conference.
Researchers at Karolinska Institutet in Sweden have imaged tau protein in the brains of living patients with Alzheimer's disease.
The desire for a quick-fix for obesity fuels a lucrative market in so-called natural remedies. But a study of medical records in Hong Kong revealed 66 cases where people were suspected to have been poisoned by a "natural" slimming therapy. In eight cases the people became severely ill, and in one case the person died. The study is published today in the British Journal of Clinical Pharmacology.
Hythiam, Inc. (NASDAQ:HYTM) announced today that on September 15, 2009, the Company received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock had closed below the minimum $1.00 per share threshold as set forth in NASDAQ Listing Rule 5450(a)(1) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.
› Verified 3 days ago
Dr. Samreen Mattoo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1225 W Lake St, Melrose Park, IL 60160 Phone: 708-938-7350 | |
Constantine G Delis, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1111 Superior St, Suite 203, Melrose Park, IL 60160 Phone: 708-338-1780 Fax: 708-338-1790 | |
Anupa Rai, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1111 Superior St, Suite 101, Melrose Park, IL 60160 Phone: 708-344-2161 | |
Dr. Peyman Pahlavan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 153 1/2 N. Broadway Avenue, Melrose Park, IL 60160 Phone: 708-345-8960 Fax: 708-345-8965 | |
Dr. Rachel Elizabeth Burt Kadar, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 675 W North Ave Ste 505, Melrose Park, IL 60160 Phone: 708-450-4557 Fax: 708-338-0200 | |
Dr. Vijay Yeldandi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 Superior St, 5th Floor, Melrose Park, IL 60160 Phone: 773-205-4661 Fax: 708-938-7098 | |
David R Rosi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 715 W North Ave, Melrose Park, IL 60160 Phone: 708-327-1518 Fax: 708-327-1501 |